Rhythm Pharmaceuticals (MEX:RYTM) 5-Day RSI: N/A (As of Jul. 05, 2026)


MEX:RYTM Rhythm Pharmaceuticals Inc MEX:RYTM
55 GF Score
Price MXN1,866.76
GF Value MXN1,817.22
! 3 Warning Signs
View Full Analysis

What is Rhythm Pharmaceuticals 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-05), Rhythm Pharmaceuticals's 5-Day RSI is N/A.

The industry rank for Rhythm Pharmaceuticals's 5-Day RSI or its related term are showing as below:

MEX:RYTM's 5-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 58.18
* Ranked among companies with meaningful 5-Day RSI only.

Rhythm Pharmaceuticals  (MEX:RYTM) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Rhythm Pharmaceuticals 5-Day RSI Related Terms


MEX:RYTM vs MIRM, SYRE, PTGX: 5-Day RSI Comparison

For the Biotechnology subindustry, Rhythm Pharmaceuticals's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhythm Pharmaceuticals 5-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rhythm Pharmaceuticals's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Rhythm Pharmaceuticals's 5-Day RSI falls into.


MEX:RYTM
55GF Score
Rhythm Pharmaceuticals Inc MEX:RYTM
5-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhythm Pharmaceuticals  (MEX:RYTM) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Rhythm Pharmaceuticals (MEX:RYTM) Overvalued in 2026?

Based on GuruFocus' analysis, Rhythm Pharmaceuticals stock appears to be overvalued. The current stock price of MXN1,866.76 is trading 2.7% above its estimated GF Value™ of MXN1,817.22.

Key valuation signals for MEX:RYTM:

  • 5-Day RSI: N/A
  • GF Value™: MXN1,817.22 vs. price of MXN1,866.76 (2.7% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the MEX:RYTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhythm Pharmaceuticals Business Description

Other Exchanges RYTM:USA1RV:Germany
Address 222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
55GF Score

Get the complete analysis for MEX:RYTM

5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,866.76
Price
MXN1,817.22
GF Value